Bank Of America Corp Harpoon Therapeutics, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.55 - $0.82 $11,933 - $17,791	-21,697 Reduced 96.65%	752 $0
Q1 2023 May 12, 2023	BUY	$0.65 - $1.37 $13,055 - $27,517	20,086 Added 850.02%	22,449 $16,000
Q4 2022 Feb 10, 2023	BUY	$0.6 - $1.41 $177 - $417	296 Added 14.32%	2,363 $1,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $2.56 $861 - $2,347	917 Added 79.74%	2,067 $2,000
Q2 2022 Aug 12, 2022	SELL	$1.78 - $5.02 $6,578 - $18,553	-3,696 Reduced 76.27%	1,150 $2,000
Q1 2022 May 16, 2022	SELL	$3.54 - $8.08 $16,457 - $37,563	-4,649 Reduced 48.96%	4,846 $24,000
Q4 2021 Feb 08, 2022	SELL	$5.69 - $7.83 $13,894 - $19,120	-2,442 Reduced 20.46%	9,495 $72,000
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $46,996 - $83,496	5,964 Added 99.85%	11,937 $94,000
Q2 2021 Sep 13, 2021	BUY	$13.81 - $23.25 $82,487 - $138,872	5,973 New	5,973 $83,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.